The Effect of Foot Massage With Roles on Cancer Patients

Breast Neoplasms Clinical Trial

Official title:

Roles in the Management of Treatment-Induced Peripheral Neuropathy in Cancer Patients Receiving Taxane-Based Chemotherapy and the Effect of Foot Massage on Neuropathy and Quality of Life: A Randomized Controlled Study

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

• NCT number: NCT06376357
• Other study ID #: 16.04.24/1
• Status: Enrolling by invitation
• Phase: N/A
• Start date: April 27, 2024
• Est. completion date: July 30, 2024

Study information

• Verified date: April 2024
• Source: Selcuk University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

It was aimed to examine the roles in the management of treatment-related peripheral neuropathy in cancer patients receiving taxane-based chemotherapy and the effect of foot massage on neuropathy and quality of life.

Description:

Intervention Phase of the Research; 1. Patient information about neuropathy caused by chemotherapy and its management, 2. Teaching the role application to the patient, 3. Application process 4. It will be carried out in 4 steps, including patient monitoring via telemonitoring.

Recruitment information / eligibility

• Status: Enrolling by invitation
• Enrollment: 54
• Est. completion date: July 30, 2024
• Est. primary completion date: June 15, 2024
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Being registered in the medical oncology outpatient clinic of Selçuk University Faculty of Medicine Hospital
• Completed standard taxane-based chemotherapy treatment protocol for breast and ovarian cancer
• Karnofsky Performance Scale being 80 and above (Performance scale of cancer patients)
• Being 18 years or older
• Having received at least 3 cycles of taxane-based treatment
• Presence of grade 2 or higher peripheral neuropathy
• Being conscious and cooperative
• Verbal and written approval to participate in the study after an explanation about the study is made.

Exclusion Criteria:

• Previous skin sensitivity on hands and feet
• Refused to participate in the study after making a statement about the study
• Development of peripheral neuropathy due to reasons other than chemotherapy [tumor compression, nutritional disorders, infections or major systemic disease (diabetes mellitus, etc.)]
• Bone, spine metastasis or malignancy
• Having mental and psychic problems that would prevent him from taking part in the research.

Related Conditions & MeSH terms

• Breast Neoplasms

Intervention

Other:
• Foot Massage with roller
The intervention group is expected to apply roller massage to the soles of both feet in a sitting position on a chair (8 hours apart at 08.00, 16.00, 24.00 hours) every day for 6 weeks, 3x5 minutes a day. Video recording will be used as a reminder in the application.

Locations

Country	Name	City	State
Turkey	ülkü Saygili Düzova	Selçuklu	Konya

Sponsors (1)

Lead Sponsor	Collaborator
Selcuk University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	EORTC QLQ C-30 Quality of Life Scale	Quality of life of patients will be evaluated with EORTC QLQ-C30, which was developed by EORTC for cancer patients and is widely used all over the world.	10 minutes
Primary	CIPN20 Neuropathy Scale	It is a 20-item assessment tool used to reveal the symptoms of chemotherapy-related peripheral neuropathy and the impact of functional limitations caused by this problem on patients' lives.	10 minutes
Primary	One Leg Standing Test	The Single Leg Standing Test (TAUDT), which is widely used to evaluate static balance, is a simple test that can be used in many situations and requires minimal equipment.	5 minutes
Primary	Brief Pain Inventory BPI	The BPI questionnaire is a short, easy-to-apply assessment method that can be used to evaluate pain and related functions (general activity, walking ability, normal work, relationships with other people, sleep, enjoyment of life). It includes simple 0 to 10 numerical rating scales that are both easy to understand and easy to translate into different languages. In the short pain inventory, the mildest pain score = 0 and the most severe pain score = 10.	5 minutes
Primary	Pain Threshold Assessment Test	algometer (Baseline, USA) will be used. The Algometer (Relevant material is located in Selçuk University SHMYO application laboratory and it is planned to be taken and used with a report for the study and returned after the last measurements) is positioned upright and the pressure is increased to 1kg/cm2 at the painful point every three seconds and the measurements are taken with a 30-second rest period in between. It is applied 3 times and the average of 3 measurements is used for analysis.	5 minutes
Primary	Two Point Discrimination	Evaluation will be made from the trans-metatarsal area, middle of the foot and middle of the heel. It will start from the interval where two points can be easily distinguished. The distance between two points will be reduced in 1 mm intervals until the two points are felt as a single point. Then, it will start with two-point stimulation at the minimum interval felt as a single point, and the distance between the two points will be increased in 1 mm intervals until the distance between the two points is felt separately as two points again.	10 minutes